Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for $490 million. Piramal Pharma will use the capital injection to accelerate its organic and inorganic growth plans. This transaction is one of the largest private equity deals in the Indian pharmaceutical...